scientific program • symposia - American Society for Reproductive ...

SCIENTIFIC PROGRAM • INTERACTIVE SESSIONS
Tuesday, October 18, 2011 1:15 pm – 2:15 pm
Interactive Session
SHOULD CHROMOSOME TESTING OF THE PRODUCTS
OF CONCEPTION BE ROUTINELY PERFORMED AT THE TIME
OF THE SECOND MISCARRIAGE?
Presented by the Reproductive Immunology Special Interest Group and
the Society for Reproductive Endocrinology and Infertility
Ruth B. Lathi, M.D. (Chair)
Stanford University
Mary Stephenson, M.D., M.Sc.
University of Chicago
Lee R. Hickock, M.D.
University of Washington
Needs Assessment and Description
Miscarriage is one of the most common complications of a
pregnancy. Patients with a history of 2 or more miscarriages
are at increased risk for recurrence, and often an evaluation
is recommended at this point. Numeric chromosomal
abnormalities account for over half of all miscarriages, yet
testing miscarriages for chromosomal errors is rarely done.
INFORMED CONSENT: THE ROLE OF THE REI NURSE
Joint session presented by the Nurses’ Professional Group and the Legal
Professional Group
Margaret Swain, R.N., J.D. (Chair)
Private Practice
Maria M. Jackson, R.N., B.S., M.A.
St. Barnabas Medical Center
Needs Assessment and Description
Within the context of the law, the doctrine of informed
consent reflects the legal concepts and statutory mandates
governing interactions of medical providers with their
patients during the informed consent process. After
reviewing the historical and conceptual aspects of this area,
discussion will focus on the applied concept of informed
consent within ART nursing practice. A recent survey of
ASRM members indicated an interest in this subject.
Learning Objectives
At the conclusion of this session, participants should be able
to:
1. Discuss the development and purpose of the doctrine of
informed consent.
2. Identify proper content and delivery of the informed
consent discussion in ART.
3. Define the role of the professional nurse in the ART
informed consent process.
Room 230 D
88
Learning Objectives
At the conclusion of this session, participants should be able
to:
1. Describe benefits of testing miscarriage tissue for
chromosomes.
2. Identify costs, barriers and limitations of cytogenetic
testing of products of conception.
3. Discuss the impact on clinical management of patients
with a history of 2 or more miscarriages.
ACGME COMPETENCY
Medical Knowledge
Patient Care
TEST QUESTION:
For patients experiencing a miscarriage, after participating
in this session, in my practice I will do chromosomal testing
on products of conception:
A. For every miscarriage.
B. For the second (or higher number) miscarriage.
C. Only if the loss occurs after 8 gestational weeks.
D. Only by patient request.
E. Not applicable to my area of practice.
Tuesday, October 18, 2011 1:15 pm – 2:15 pm
Interactive Session
Room 230 C
ACGME COMPETENCY
Patient Care
Interpersonal and Communication Skills
TEST QUESTION:
After participating in this session, I will do the following in my
practice:
A. Not use an informed consent document.
B. Use a facility-provided general consent form.
C. Provide the informed consent document to patients for
their review prior to their physician-conducted informed
consent discussion.
D. Never encourage the patient to question the physician
about a procedure, since the nurse is available to answer
all questions.
E. Not applicable to my area of practice.